A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease

por Maher-Edwards, Gareth, De'Ath, Jeni, Barnett, Carly, Lavrov, Arseniy, Lockhart, Andrew
Publicado 2015